Formation of 1,2,3,4-tetrahydro-β-carboline and methylene-β-phenylethylimine from 5-methyltetrahydrofolate and amines in tissues from developing rat brain

The rates of synthesis of 1,2,3,4-tetrahydro-β-carboline (THβC) and methylene-β-phenylethylimine (MβΦEI) from 5-methyltetrahydrofolate (5-MTHF) and tryptamine and β-phenylethylamine (βΦEA) respectively have been measured in cerebellum, corpus striatum, and the remainder of the brain from male and female rats at six specific ages after birth. With either substrate the specific activity of the reaction was higher in cerebellum than in corpus striatum until approximately 31 days after birth. The fluctuations in neonatal production of THβC and MβΦEI in cerebellum were nearly parallel except around six days, when THβC production peaked and MβΦEI production dropped considerably. The regional differences in the neonatal patterns of THβC and MβΦEI formation hint that the formaldehyde-forming enzyme (whether or not it is methylane-tetrahydrofolate reductase as we believe) might be related to structural and functional development in specific brain regions.     

ENZYMATIC FORMATION OF TETRAHYDRO-β-CARBOLINE FROM TRYPTAMINE AND 5-METHYLTETRAHYDROFOLIC ACID IN RAT BRAIN FRACTIONS: REGIONAL AND SUBCELLULAR DISTRIBUTION

—In rat brain extract tryptamine is converted to 1,2,3,4-tetrahydro-β-carboline (THβJC) and N-methyltryptamine to 2-methyl-THβC in the presence of 5-methyltetrahydrofolic acid. We believe this occurs through enzymatic conversion of 5-methyltetrahydrofolic acid to formaldehyde and tetrahydrofolic acid, followed by spontaneous condensation of the radioactive formaldehyde with the substrate tryptamine (Donaldson & Keresztesy , 1961). The final products of the reactions have been identified by both thin layer chromatography and mass spectrophotometry. Subcellular fractionation shows more than 90 per cent of the formaldehyde-forming enzyme activity to be in the cytosol. Specific activities in fractions from 16 discrete regions of the brain and CNS range from 210·2 ± pmol of THβC/mg protein/h in corpus striatum to 62·9 ± 3·6 pmol of THβC/mg protein/h in corpus callosum.     

On the mode of formation of tetrahydro-beta carbolines.

The condensation of tetrahydro-β-carboline (TBC) takes place if serotonin is incubated with 5-MTHF and the cytosol fraction from rat brain as an enzymatic source. Such a formation occurs to a lesser extent if the enzyme(s) is omitted from the incubation mixture. The conditions of the enzymatic as well as the non-enzymatic mode of formation of TBC are investigated. It could be shown by addition of semicarbazide to the incubation medium that formaldehyde is an intermediate in the production of TBC. The biological significance of TBC will be discussed.     

Effect of a test meal,duodenal acidification,and tetragastrin on the plasma concentration of β-endorphin-like immunoreactivity in man

The effects of various test materials on plasma β-endorphin-like immunoreactivity (β-EpLI) were investigated in man using a specific radioimmunoassay developed by the authors. Plasma β-EpLI was determined after extraction by the acid/acetone method (recovery 73±5%). The intraassay and interassay coefficients of variation were 5.0% and 7.6%, respectively. The plasma concentrations of human β-EpLI in normal subjects were 11.6±4.0 pmol/l for men (n=23) and 10.7±4.8 pmol/l for women (n=27). Ingestion of a test meal (150 g of Campbell's condensed meat soup) resulted in a biphasic rise in plasma β-EpLI from the basal level of 4.4±1.0 pmol/l to 29.2±1.9 pmol/l after 5 min and 24.8±6.7 pmol/l after 90 min. Intraduodenal infusion of 115 ml of 0.1 M HCl over 10 min increased the plasma β-EpLI level from 8.7±0.5 pmol/l to 15.5±0.4 pmol/l at 10 min after the start of infusion, but the level rapidly returned to the initial value after the end of the infusion. Intramuscular injection of 4 μg/kg body weight of tetragastrin markedly stimulated gastric acid output and β-EpLI release, but pretreatment with 10 mg of histamine H₂ receptor antagonist inhibited the gastric acid output and plasma β-EpLI release induced by tetragastrin.These results indicate that β-EpLI release is stimulated by ingestion of meat soup, duodenal acidification and tetragastrin administration. It is suggested that gastric acid participates, at least in part, in postprandial release of β-EpLI, probably from the gastrointestinal tract.     

Presence of immunoassayable beta-lipotropin in bovine brain and spinal cord: lack of concordance with ACTH concentrations.

Discrete areas of freshly obtained adult bovine brain were assayed for their content of immunoreactive β-lipotropin (β-LPH), ACTH and β-endorphin. Highest concentrations (pg/100ug protein) of β-LPH were present in hypothalamus (517 ± 81), hippocampus (218 ± 60), central grey rostral mesencephalic level, pons, striatum, and spinal cord (163–258). Lesser concentrations (49–138) were present in other parts of the limbic system, brain stem, cortex and thalamus. Immunoreactive ACTH concentrations were highest in hypothalamus (1702 ± 487) and hippocampus (210 ± 40), with markedly lesser concentrations (5–24) being present in all the other aforementioned areas. Immunoreactive β-endorphin concentrations in hypothalamus were 1990 ± 510, in hippocampus 280 ± 50.     

AMINE FORMATION FROM l-TRYPTOPHAN IN BRAIN SLICES

Abstract— Slices from four areas of guinea-pig brain (hypothalamus, corpus striatum, median ponsmedulla and cerebral cortex) were incubated with concentrations of l -[3-¹⁴C]tryptophan varying from 20 to 300 μ m . in the presence of 5 × 10^-5 m -pargyline. The formation of tryptamine and serotonin was studied.
Serotonin synthesis reached its highest level at a concentration of approx 80 μ m -tryptophan in all 4 brain areas. Activity was high in pons-medulla and hypothalamus but only about one third as high in corpus striatum and cortex.
Tryptamine formation continued to increase within the concentration range of tryptophan used. Activity was high in corpus striatum where, at 300 μ m -tryptophan, tryptamine formation exceeded serotonin formation, but was low in cortex and intermediate in pons-medulla and hypothalamus.
The possible formation of kynuramine and 5-hydroxykynuramine was also investigated. No evidence was obtained for the formation of 5-hydroxykynuramine. Traces of radioactivity were found corresponding to kynuramine, but these were insufficient to establish its formation with certainty. If formed. the rate of kynuramine synthesis did not exceed 2% of the combined formation of serotonin and tryptamine.     

Multiple N-methyltransferases for aromatic alkylamines in brain

This report describes our studies of the enzymatic N-methylation of tryptamine and β-phenylethylamine by fractions of homogenized rat brain with either 5-methyltetrahydrofolic acid (5-MTHF) or S-adenosyl-L-methionine (SAM) as the methyl donor. We found the pH optimum between 6.5 and 7.0 in reaction involving 5-MTHF and either substrate. (We confirmed reports that reactions involving SAM have a pH optimum of 7.9 with either substrate). Enzymatic activity in the presence of 5-MTHF was linear with time and protein concentration. Measures of enzymatic activity in the 100,000 x g supernate of whole rat brain homogenerate were enriched 15–25 fold after Sephadex G-100 fractionation of the 40–50% ammonium sulfate precipitate. Dialysis enhanced the enzyme activity in virtually all of the fractions. Blanks with tryptamine and boiled enzyme gave unexpectedly high counts (comparable to those without enzyme), suggesting possible non-enzymatic methylation in addition to enzymatic N-methylation. We controlled for this by using blanks of substrate plus boiled enzyme. Radioactive products were isographic with N-monomethyltryptamine and N,N-dimethyl tryptamine on thin layer chromatograms. In the presence of 5-MTHF there is low enzymatic affinity (Km = approximately 10^?3 M) for either substrate, suggesting that enzymatic N-methylation might occur only when amine concentrations are abnormally high. Assays in the presence of each donor in combination with each substrate suggested the possible existence of multiple N-methyltransferases, with one specific for tryptamine and the others non-specific for aromatic alkylamines.     

Nicotinic acetylcholine receptor of mammalian brain: naja toxin binding to subcellular fractions of rat brain

Abstract— Subcellular fractions of rat brain cortex bound 6.8 ± 0.4 fmol of ¹²⁵I-labeled α-naja toxin per milligram of protein. Toxin binding was saturable and specific e.g. nicotinic agonist and antagonist blockable. Regions in rat brain varied in saturable, specific toxin binding with hippocampus, olfactory area and corpus striatum displaying greatest toxin binding. We conclude that ¹²⁵I-α-naja toxin is a suitable probe for nicotinic cholinergic receptor in brain.     

The occurrence of 2-methyl-1,2,3,4-tetrahydro-β-carboline and variation in alkaloids in Phalaris arundinacea

2-Methyl-1,2,3,4-tetrahydro-β-carboline was isolated from reed canarygrass (Phalaris arundinacea L.) and the occurrence of 2-methyl-6-methoxy-1,2,3,4-tetrahydro-β-carboline confirmed. Clones of reed canarygrass that contained N,N-dimethyltryptamine or 2-methyl-1,2,3,4-tetrahydro-β-carboline did not contain their respective methoxy or hydroxy derivatives. Five of the 12 clones tested contained either or both of 5-methoxy-N,N-dimethyltryptamine and 2-methyl-6-methoxy-1,2,3,4-tetrahydro-β-carboline. The data suggest that clones that contain gramine are not likely to contain N,N-dimethyltryptamine and/or β-carbolines. Thus, an inverse biosynthetic relationship between gramine and the tryptamine and β-carboline alkaloids seems to exist. However, further work is needed to firmly establish any such relationship between these alkaloids.     

Synthesis and investigations into the anticancer and antibacterial activity studies of β-carboline chalcones and their bromide salts

A series of sixteen β-carbolines, bearing chalcone moiety at C-1 position, were prepared from easily accessible 1-acetyl-β-carboline and various aldehydes under basic conditions followed by N²-alkylation using different alkyl bromides. The prepared compounds were evaluated for in vitro cytotoxicity against a panel of human tumor cell lines. N²-Alkylated-β-carboline chalcones 13a-i represented the interesting anticancer activities compared to N²-unsubstituted β-carboline chalcones 12a-g. Off the prepared β-carbolines, 13g exhibited broad spectrum of activity with IC₅₀ values lower than 22.5?µM against all the tested cancer cell lines. Further, the N²-alkylated-β-carboline chalcone 13g markedly induced cell death in MDA-MB-231 cells by AO/EB staining assay. The most cytotoxic compound 13g possessed a relatively high drug score of 0.48. Additionally, the prepared β-carboline chalcones displayed moderate antibacterial activities against tested bacterial strains.     

Design, synthesis and biological evaluation of β-carboline derivatives as novel inhibitors targeting B-Raf kinase

β-Carboline family of compounds is a large group of alkaloids widely distributed in nature and exhibits broad-spectrum anti-tumor activities. We designed and synthesized two series of novel 1-carboxamide- and 6-sulfonamide-substituted β-carboline derivatives 7a-p and 12a-b, and their wild type B-Raf kinase inhibitory activities were described. Most compounds showed moderate to excellent inhibitory activities. Among them, 1-carboxamide-6-(N-(3-(dimethylamino)propyl)-sulfamoyl)-β-carboline, 7e exhibited potent activity (IC(50)=1.62 μM), showing the potential for further investigation as a lead compound.     

CYCLIC AMP AND PHOSPHODIESTERASE IN SYNAPTIC VESICLES FROM MOUSE BRAIN

The isolation of synaptic vesicles from mouse brain by a modification of previously reported methodology is described. Homogeneity of the preparations was ascertained by electron microscopy. Vesicles thus isolated contained cyclic AMP (365 ± 44 pmol/mg of protein; mean ± S.E.M.) and adenosine 3′,5′-monophosphate phosphodiesterase activity (500 pmol/mg of protein per 30 min). The number of vesicles in three of the vesicle preparations was determined by a visual count of grid fields under the electron microscope. The content of cyclic AMP in the vesicles was calculated at 5000-7500 molecules/vesiclc. The presence of cyclic AMP in the synaptic vesicles from presynaptic nerve endings would support a role for this nucleotide in nerve transmission.     

Evidence for cross-talk between atrial natriuretic peptide and nitric oxide receptors

Guanylyl cyclases (GCs), a ubiquitous family of enzymes that metabolize GTP to cyclic GMP (cGMP), are traditionally divided into membrane-bound forms (GC-A-G) that are activated by peptides and cytosolic forms that are activated by nitric oxide (NO) and carbon monoxide. However, recent data has shown that NO activated GC’s (NOGC) also may be associated with membranes. In the present study, interactions of guanylyl cyclase A (GC-A), a caveolae-associated, membrane-bound, homodimer activated by atrial natriuretic peptide (ANP), with NOGC, a heme-containing heterodimer (α/β) β1 isoform of the β subunit of NOGC (NOGCβ1) was specifically focused. NOGCβ1 co-localized with GC-A and caveolin on the membrane in human kidney (HK-2) cells. Interaction of GC-A with NOGCβ1 was found using immunoprecipitations. In a second set of experiments, the possibility that NOGCβ1 regulates signaling by GC-A in HK-2 cells was explored. ANP-stimulated membrane guanylyl cyclase activity (0.05 ± 0.006 pmol/mg protein/5 min; P < 0.01) and intra cellular GMP (18.1 ± 3.4 vs. 1.2 ± 0.5 pmol/mg protein; P < 0.01) were reduced in cells in which NOGCβ1 abundance was reduced using specific siRNA to NOGCβ1. On the other hand, ANP-stimulated cGMP formation was increased in cells transiently transfected with NOGCβ1 (530.2 ± 141.4 vs. 26.1 ± 13.6 pmol/mg protein; P < 0.01). siRNA to NOGCβ1 attenuated inhibition of basolateral Na/K ATPase activity by ANP (192 ± 22 vs. 92 ± 9 nmol phosphate/mg protein/min; P < 0.05). In summary, the results show that NOGCβ1 and GC-A interact and that NOGCβ1 regulates ANP signaling in HK-2 cells. The results raise the novel possibility of cross-talk between NOGC and GC-A signaling pathways in membrane caveolae.     

6-Methoxyl-1,2,3,4-tetrahydro-beta-carboline effects on retinal serotonin

The compound 6-Methoxy-1, 2, 3, 4-tetrahydro-β-carboline (6-MeO-THβC) belonging to the group of hallucinogenic β-carbolines has been found to alter various aspects of serotonergic transmission in the brain. The action of 6-MeO-THβC on the newly identified 5-HT system of bovine retina was studied $\text{in vitro}$. The drug inhibited the high affinity uptake of [³H] 5-HT in a competitive manner and had no evident effect on the uptake of dopamine or GABA. In addition the compound increased the potassium evoked release of 5-HT from retina. Endogenous β-carbolines have been proposed to be involved in the modulation of serotonergic activity in the brain and a similar action is proposed in the retina. In addition these findings raise the possibility of retinal 5-HT system as a site of action for β-carbolines and similar hallucinogenic drugs.     

Phenylethanolamine N-methyltransferase has beta-carboline 2N-methyltransferase activity: hypothetical relevance to Parkinson's disease

Mammalian brain has a β-carboline 2N-methyltransferase activity that converts β-carbolines, such as norharman and harman, into 2N-methylated β-carbolinium cations, which are structural and functional analogs of the Parkinsonian-inducing toxin 1-methyl-4-phenylpyridinium cation (MPP⁺). The identity and physiological function of this β-carboline 2N-methylation activity was previously unknown. We report pharmacological and biochemical evidence that phenylethanolamine N-methyltransferase (EC 2.1.1.28) has β-carboline 2N-methyltransferase activity. Specifically, purified phenylethanolamine N-methyltransferase (PNMT) catalyzes the 2N-methylation (21.1 pmol/h per unit PNMT) of 9-methylnorharman, but not the 9N-methylation of 2-methylnorharmanium cation. LY134046, a selective inhibitor of phenylethanolamine N-methyltransferase, inhibits (IC₅₀ 1.9 μM) the 2N-methylation of 9-methylnorharman, a substrate for β-carboline 2N-methyltransferase. Substrates of phenylethanolamine N-methyltransferase also inhibit β-carboline 2N-methyltransferase activity in a concentration-dependent manner. β-Carboline 2N-methyltransferase activity (43.7 pmol/h/mg protein) is present in human adrenal medulla, a tissue with high phenylethanolamine N-methyltransferase activity.

We are investigating the potential role of N-methylated β-carbolinium cations in the pathogenesis of idiopathic Parkinson’s disease. Presuming that phenylethanolamine N-methyltransferase activity forms toxic 2N-methylated β-carbolinium cations, we propose a novel hypothesis regarding Parkinson’s disease—a hypothesis that includes a role for phenylethanolamine N-methyltransferase-catalyzed formation of MPP⁺-like 2N-methylated β-carbolinium cations.     

Stereoselective preparation of pyridoxal 1,2,3,4-tetrahydro-β-carboline derivatives and the influence of their absolute and relative configuration on the proliferation of the malaria parasite Plasmodium falciparum

We have selectively synthesized by Pictet–Spengler condensation of tryptophan and pyridoxal the four stereoisomers of a pyridoxal β-carboline derivative that was designed to inhibit the proliferation of Plasmodium falciparum. Biological investigation of the four compounds revealed that they all inhibit the growth of P. falciparum. With an IC₅₀ value of 8 ± 1 μM, the highest inhibitory effect on the proliferation of the parasite was found for the 1,3-trans-substituted tetrahydro-β-carboline that was obtained from d-tryptophan. Lower activity was found for its enantiomer, while the two diastereomeric cis-products were markedly less effective. Apparently a distinct spacial orientation of the carboxyl group of the substituted tetrahydropyridine unit of the compounds is needed for high activity, while the absolute configuration of the molecules is of lesser importance.     

New alkaloids from Banisteriopsis caapi

Three new alkaloids isolated from Banisteriopsis caapi, were identified as harmic amide (1-carbamoyl-7-methoxy β-carboline), acetyl norharmine (1-acetyl-7-methoxy β-carboline) and ketotetrahydronorharmine (7-methoxy-1,2,3,4-tetrahydro-1-oxo-β-carboline)     

Pharmacokinetic and pharmacodynamic factors contributing to the convulsant action of β-carboline-3-carboxylic acid esters

Both the methyl ester of β-carboline-3-carboxylic acid and the 6, 7-dimethoxy-4-ethyl derivative of this compound are potent convulsants in rodents, while the ethyl ester of β-carboline-3-carboxylic acid does not cause convulsions, even when administered at very high doses. The rate of degradation of these compounds by rat plasma ($\text{in vitro}$) parallels their potencies as convulsants. In contrast, 3-carboethoxy-β-carboline was found to potently elicit tonic and clonic convulsions in the squirrel monkey ($\text{Saimiri sciureus}$). Furthermore, the rate of degradation of 3-carboethoxy-β-carboline in monkey plasma ($\text{in vitro}$) is negligible compared with rats. No significant differences were observed in either the potency or efficacy of GABA to inhibit [³H] β-carboethoxy-β-carboline binding in rat and monkey brain. These data strongly suggest that pharmacokinetic, as well as pharmacodynamic, factors may determine the pharmacologic profile of these β-carboline-3-carboxylic acid esters.     

Harman in human platelets.

The β-carbolines present in human platelets have been extracted with diethyl ether, isolated by liquid column chromatography and thin-layer chromatography (TLC), and identified by ultraviolet fluorimetry, gas liquid chromatography (GC) and mass spectrometry (MS). Harman (1-methyl-β-carboline) was the only β-carboline unequivocally identified in platelet samples with these techniques. Since harman is thought to be biosynthesized by the condensation of tryptamine and acetaldehyde, its formation may be of importance in the metabolism and the pharmacological-toxicological actions of alcohol.